Atlas Trials

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

Clinical trial NCT05855369 · RECRUITING

Trial details

NCT number
NCT05855369
Sponsor
Medical University of South Carolina
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Smell DysfunctionOlfactory DisorderLong COVID
Start date
2023-10-02
Primary completion
2028-05-31
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.